CN1606986A - 江南卷柏醇提干粉及其制备方法 - Google Patents
江南卷柏醇提干粉及其制备方法 Download PDFInfo
- Publication number
- CN1606986A CN1606986A CN 200310100257 CN200310100257A CN1606986A CN 1606986 A CN1606986 A CN 1606986A CN 200310100257 CN200310100257 CN 200310100257 CN 200310100257 A CN200310100257 A CN 200310100257A CN 1606986 A CN1606986 A CN 1606986A
- Authority
- CN
- China
- Prior art keywords
- herba selaginellae
- selaginellae involventis
- dry powder
- preparation
- involventis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims description 17
- 241000015737 Selaginella moellendorffii Species 0.000 title description 2
- 241000282461 Canis lupus Species 0.000 title 1
- 239000006286 aqueous extract Substances 0.000 claims abstract description 33
- 239000002994 raw material Substances 0.000 claims abstract description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 208000032843 Hemorrhage Diseases 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 6
- 206010053476 Traumatic haemorrhage Diseases 0.000 claims description 5
- 230000008030 elimination Effects 0.000 claims description 5
- 238000003379 elimination reaction Methods 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 229940030225 antihemorrhagics Drugs 0.000 claims description 4
- 230000000025 haemostatic effect Effects 0.000 claims description 4
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- -1 reflux Substances 0.000 claims description 2
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 2
- 238000002481 ethanol extraction Methods 0.000 description 31
- 238000001914 filtration Methods 0.000 description 12
- 230000000740 bleeding effect Effects 0.000 description 9
- 230000003292 diminished effect Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 241000581650 Ivesia Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000006837 decompression Effects 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical group O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 3
- 206010053567 Coagulopathies Diseases 0.000 description 2
- HBGOLJKPSFNJSD-UHFFFAOYSA-N Etamsylate Chemical compound CC[NH2+]CC.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 HBGOLJKPSFNJSD-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960004817 etamsylate Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000013210 evaluation model Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
水浸膏量(g) | 乙醇浓度(%) | 冻干粉重(g) | 收率(%) |
50 | 30 | 30.0200 | 60.0 |
50 | 50 | 32.6252 | 65.2 |
50 | 70 | 25.0158 | 50.0 |
50 | 95 | 29.3496 | 58.7 |
t/min | (甲醇)/% | (水)/% |
0 | 20 | 80 |
10 | 40 | 60 |
50 | 100 | 0 |
75 | 100 | 0 |
77 | 20 | 80 |
组别 | 剂量(mg/kg·d) | 凝血时间(S) |
NS | - | 1385±206 |
止血敏 | 26.8 | 931±229 |
江南卷柏水浸膏 | 26.8 | 932±254 |
30%乙醇提取物 | 26.8 | 488±161a |
50%乙醇提取物 | 26.8 | 944±204 |
70%乙醇提取物 | 26.8 | 944±358 |
95%乙醇提取物 | 26.8 | 856±138 |
组别 | 剂量(mg/kg·d) | 凝血时间(s) |
NS | - | 1287±269 |
低剂量组 | 0.067 | 1266±126 |
中剂量组 | 0.134 | 725±311a |
高剂量组 | 0.268 | 447±218b |
峰号 | 保留时间(min) | 峰面积 | ||||
江南卷柏水浸膏 | 30%乙醇提取物 | 50%乙醇提取物 | 70%乙醇提取物 | 95%乙醇提取物 | ||
1 | 1.490 | 58964 | ||||
2 | 1.491 | 76423 | ||||
3 | 1.570 | 10517 | 101438 | |||
4 | 1.588 | 80273* | ||||
5 | 1.674 | 78565 | ||||
6 | 1.722 | 79934 | 109995 | |||
7 | 1.724 | 22666 | 45748 | |||
8 | 2.010 | 56119 | 68741 |
9 | 2.050 | 587076 | 494463 | |||
10 | 2.072 | 530903 | ||||
11 | 2.215 | 246816 | ||||
12 | 2.227 | 387016 | ||||
13 | 2.248 | 276483 | ||||
14 | 2.263 | 293464* | ||||
15 | 2.427 | 513997 | ||||
16 | 2.468 | 37089 | ||||
17 | 2.495 | 125367 |
峰号 | 保留时间(min) | 峰面积 | ||||
江南卷柏水浸膏 | 30%乙醇提取物 | 50%乙醇提取物 | 70%乙醇提取物 | 95%乙醇提取物 | ||
1 | 1.524 | 13264 | ||||
2 | 1.541 | 12411 | ||||
3 | 1.591 | 17369 | ||||
4 | 1.591 | 15617 | ||||
5 | 1.613 | 13624* | ||||
6 | 1.670 | 23166 | ||||
7 | 1.704 | 22039 | ||||
8 | 1.724 | 31527* | ||||
9 | 1.73 | 42298 | 55907 | |||
10 | 1.82 | 17536 | 27008 | 26415 | ||
11 | 2.01 | 17750 | 20494 | 20176 | ||
12 | 2.02 | 25319 | 27345 |
13 | 2.199 | 106804 | ||||
14 | 2.211 | 162800 | ||||
15 | 2.234 | 105310 | ||||
16 | 2.249 | 124770* | ||||
17 | 2.261 | 64507 | ||||
18 | 2.934 | 15693 | ||||
19 | 3.46 | 22225 | 32328 | 29116 | 24321 | 53567 |
20 | 4.04 | 22535 | 36026 | 33041 | 24942 | 32758 |
21 | 7.9 | 2465 | 9860 | 8949 | 11692 | 10735 |
22 | 11.7 | 1935 | 3454 | 4972 | 8203 | 9173 |
23 | 12.7 | 8181 | 17004 | |||
24 | 13.05 | 7852 | 10999 | 9047 | ||
25 | 13.23 | 9152 | 13631 | |||
26 | 13.78 | 2177 | 2390 | 2543 | ||
27 | 15.3 | 7258 | 4315 | 5923 | 4737 | 13064 |
28 | 27.4 | 1890 | 5375 | 6176 | ||
29 | 28.6 | 1508 | 4367 | 12632 | ||
30 | 30.441 | 10080 | ||||
31 | 30.519 | 26081 | ||||
32 | 30.569 | 81951* |
峰号 | 保留时间(min) | 峰面积 | ||||
江南卷柏水浸膏 | 30%乙醇提取物 | 50%乙醇提取物 | 70%乙醇提取物 | 95%乙醇提取物 | ||
1 | 1.591 | 10374 | ||||
2 | 1.597 | 10902 |
3 | 1.617 | 9624 | ||||
4 | 1.684 | 16561 | ||||
5 | 1.794 | 38822 | ||||
6 | 1.805 | 26317 | ||||
7 | 1.810 | 44903 | ||||
8 | 1.873 | 42753* | ||||
9 | 1.875 | 20389 | ||||
10 | 2.057 | 10797 | ||||
11 | 2.120 | 13684 | ||||
12 | 2.214 | 19098 | ||||
13 | 2.228 | 21187 | ||||
14 | 2.244 | 17011 | ||||
15 | 2.265 | 24244* | ||||
16 | 2.266 | 8463 | ||||
17 | 2.326 | 53335 | ||||
18 | 2.342 | 39704 | ||||
19 | 2.364 | 37496 | ||||
20 | 2.370 | 46367* | ||||
21 | 2.512 | 19492 | ||||
22 | 2.944 | 12900 | ||||
23 | 3.4 | 22852 | 31970 | 27147 | 30789 | 71659 |
24 | 4.0 | 22640 | 31589 | 22794 | 20223 | 40172 |
25 | 6.4 | 2119 | 2377 | 2704 | ||
26 | 7.9 | 11302 | 15625 | 14417 | 6253 | 19714 |
27 | 8.007 | 2672 | ||||
28 | 8.8 | 5318 | 4374 | 2363 | 5091 | |
29 | 10.29 | 9980 | 5153 | 2664 | ||
30 | 11.6 | 5507 | 1899 | 2042 | 9292 | 13707 |
31 | 12.67 | 11629 | 23734 | |||
32 | 13.03 | 17112 | 15861 |
33 | 13.046 | 14730 | ||||
34 | 13.202 | 9342 | 23086 | |||
35 | 13.7 | 2849 | 2977 | |||
36 | 13.847 | 3262 | ||||
37 | 14.35 | 3507 | 2840 | |||
38 | 14.174 | 1559 | ||||
39 | 14.231 | 4580 | ||||
40 | 14.313 | 1390 | ||||
41 | 14.977 | 725 | ||||
42 | 15.065 | 2459 | ||||
43 | 15.145 | 10800 | ||||
44 | 15.285 | 6338 | ||||
45 | 15.342 | 4814 | ||||
46 | 15.362 | 6070 | ||||
47 | 16.7 | 398 | 6740 | 5254 | 8644 | |
48 | 16.903 | 3885 | ||||
49 | 17.8 | 901 | 1809 | 1165 | 2240 | |
50 | 18.6 | 3471 | 4841 | 3010 | 12204 | |
51 | 18.851 | 4942 | ||||
52 | 19.531 | 398 | ||||
53 | 20.350 | 21257 | ||||
54 | 20.657 | 8639 | ||||
55 | 20.762 | 7472 | ||||
56 | 20.813 | 22643 | ||||
57 | 20.4 | 25851 | 31522 | |||
58 | 22.222 | 27765 | ||||
59 | 22.3 | 22383 | 48481 | |||
60 | 22.486 | 22679 | ||||
61 | 22.700 | 21520* | ||||
62 | 23.543 | 10276 |
63 | 23.736 | 6351 | ||||
64 | 24.524 | 5103 | ||||
65 | 24.869 | 5314 | ||||
66 | 25.137 | 2199 | ||||
67 | 26.350 | 1627 | ||||
68 | 27.5 | 2384 | 2098 | |||
69 | 27.734 | 2929 | ||||
70 | 28.5 | 11030 | 14975 | |||
71 | 28.845 | 4460 | ||||
72 | 29.9 | 7644 | 9799 | |||
73 | 30.603 | 5964 | ||||
74 | 31.455 | 1145 | 1494 | 2726 | ||
75 | 38.3 | 2668 | 1145 | 2154 | ||
76 | 53.72 | 1908 | 1294 | 2081 | ||
77 | 54.88 | 4444 | 3918 | 3758 | ||
78 | 55.74 | 2539 | 2731 | 3095 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101002576A CN100493523C (zh) | 2003-10-15 | 2003-10-15 | 江南卷柏醇提干粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101002576A CN100493523C (zh) | 2003-10-15 | 2003-10-15 | 江南卷柏醇提干粉及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1606986A true CN1606986A (zh) | 2005-04-20 |
CN100493523C CN100493523C (zh) | 2009-06-03 |
Family
ID=34755891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101002576A Expired - Lifetime CN100493523C (zh) | 2003-10-15 | 2003-10-15 | 江南卷柏醇提干粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100493523C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101332242B (zh) * | 2008-06-06 | 2012-05-30 | 罗连珍 | 一种治疗痔疮便血的汤剂药物 |
CN111297849A (zh) * | 2020-03-19 | 2020-06-19 | 中南民族大学 | 用于治疗喉癌的药物组合物、其制备方法及其应用 |
-
2003
- 2003-10-15 CN CNB2003101002576A patent/CN100493523C/zh not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101332242B (zh) * | 2008-06-06 | 2012-05-30 | 罗连珍 | 一种治疗痔疮便血的汤剂药物 |
CN111297849A (zh) * | 2020-03-19 | 2020-06-19 | 中南民族大学 | 用于治疗喉癌的药物组合物、其制备方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN100493523C (zh) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1686152A (zh) | 一种治疗慢性支气管炎的中药制剂及制备方法和应用 | |
Dayani et al. | Immunomodulatory effects of cyclotides isolated from Viola odorata in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis | |
CN103565866A (zh) | 一种三七总皂苷的制备方法 | |
CN100493523C (zh) | 江南卷柏醇提干粉及其制备方法 | |
CN1205216C (zh) | 富含红花明苷a的红花黄色素、其制备方法和含有它们的制剂及医药用途 | |
CN1771977A (zh) | 一种三七二醇皂苷组合物及其制备方法和用途 | |
CN1771978A (zh) | 一种三七三醇皂苷组合物及其制备方法和用途 | |
CN1264530C (zh) | 一种注射用参芪扶正冻干粉针剂的制备工艺 | |
CN101658542B (zh) | 软紫草总酚酸及其在制药中的用途 | |
CN1911272A (zh) | 高含量丹参多酚酸盐粉针剂及其制备方法 | |
YOKOZAWA et al. | Effect of extracts obtained from rhubarb in rats with chronic renal failure | |
CN1830465A (zh) | 香丹注射液及其制备方法 | |
CN102641347A (zh) | 一种赤芍提取物及其制备和应用方法 | |
CN1872148A (zh) | 一种治疗心脑血管疾病的注射用丹红冻干粉的制备方法及检测方法 | |
CN1241923C (zh) | 夏天无总生物碱的提取方法及其新的用途 | |
CN1546151A (zh) | 一种制备注射用参芪扶正冻干粉针剂的方法 | |
CN1278703C (zh) | 一种丹参红花冻干粉针剂 | |
CN1308679C (zh) | 一种治疗小儿肺热咳嗽口服液的质量检测方法 | |
CN1220489C (zh) | 一种注射用丹红冻干粉针剂及其制备方法 | |
CN1320891C (zh) | 一种田基黄提取物及其制备方法和用途 | |
CN1939327A (zh) | 柳川鱼苷、蒙花苷及其组合物的制药用途 | |
CN1883619A (zh) | 一种紫花地丁多糖药物组合物及其制备方法 | |
CN1891283A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN1679859A (zh) | 丹参和川芎中药有效部位的提取方法 | |
CN1219539C (zh) | 一种免疫调节剂及其在制药中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160321 Address after: Baiyun District of Guangzhou City, Guangdong province 510515 street and with the Cloud Road No. 88 Patentee after: GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS Co.,Ltd. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY Patentee after: Guangzhou Baiyun Mountain Pharmaceutical Group Limited by Share Ltd. Address before: Baiyun District of Guangzhou City, Guangdong province 510515 street and with the Cloud Road No. 88 Patentee before: Guangzhou Baiyunshan Pharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20090603 |